Status:
RECRUITING
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Lead Sponsor:
Gérond'if
Conditions:
Cardiac Amyloidosis
Eligibility:
All Genders
80+ years
Brief Summary
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last...
Detailed Description
Patients recruitment will be curry out in 31 geriatric or cardiologic centres. Patients will be recruited for 24 months. Each patient will participate in the study for 12 months (baseline visit, foll...
Eligibility Criteria
Inclusion Criteria:
- Aged ≥ 80 years
- Hospitalised for decompensation of heart failure in the last 12 months
- Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
- Subjects able to undergo a bone scintigraphy scan
- Subjects willing to participate
Exclusion Criteria:
- Subjects refusing to participate
- Subjects admitted to palliative care unit.
- Subjects under guardianship
- Subjects with a definite diagnosis of cardiac amyloidosis
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 2 2028
Estimated Enrollment :
637 Patients enrolled
Trial Details
Trial ID
NCT06427304
Start Date
July 1 2024
End Date
February 2 2028
Last Update
December 10 2025
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Geriatric Department, Broca Hospital
Paris, IIe-de-France, France, 75013
2
CHU Nantes
Nantes, Loire-Atlantique, France, 44000
3
CHU Poitiers
Poitiers, New Aquitaine, France, 86000
4
CHU Rouen, Charles Nicole hospital
Rouen, Normandy, France, 76000